Drugs / Yisui granule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05687513 | Jan 2023 → Feb 2024 | myelodysplastic syndrome | Dongzhimen Hospital, Beijing | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yisui granule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05687513 ↗ |
| Known as | YSG | “The goal of this clinical trial is to explore the mechanism of Yisui Granule(YSG) in the treatment of myelodysplastic syndrome(MDS) through demethylation.” NCT05687513 ↗ |